Current state of immunotherapy for Alzheimer's disease.
Relkin
Norman R
NR
Weill Cornell Memory Disorders Program, Weill Cornell Medical College, New York, NY, USA.
D000544:Alzheimer Disease / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D058225:Plaque, Amyloid / Q000473:pathology
C437846:AN-1792; D016229:Amyloid beta-Peptides